mefloquine has been researched along with brefeldin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chellappan, DK; Collet, TA; Dighe, SN; Dua, K; Ekwudu, O; Katavic, PL | 1 |
| Certal, M; Correia-de-Sá, P; Costa, C; Costa, MA; Ferreirinha, F; Magalhães-Cardoso, MT; Paramos-de-Carvalho, D; Pinheiro, AR; Sévigny, J | 1 |
1 review(s) available for mefloquine and brefeldin a
| Article | Year |
|---|---|
Recent update on anti-dengue drug discovery.
Topics: Animals; Antiviral Agents; Biological Products; Cell Line, Tumor; Dengue Virus; Drug Discovery; Humans; Serine Proteinase Inhibitors; Viral Nonstructural Proteins; Virus Replication | 2019 |
1 trial(s) available for mefloquine and brefeldin a
| Article | Year |
|---|---|
Histamine induces ATP release from human subcutaneous fibroblasts, via pannexin-1 hemichannels, leading to Ca2+ mobilization and cell proliferation.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Anti-Bacterial Agents; Antimalarials; Brefeldin A; Calcium; Cell Proliferation; Cells, Cultured; Collagen Type I; Connexins; Exocytosis; Female; Fibroblasts; Gene Expression Regulation; Histamine; Histamine Agonists; Humans; Male; Mast Cells; Mefloquine; Middle Aged; Nerve Tissue Proteins; Octanols; Purinergic P2Y Receptor Antagonists; Receptors, Histamine H1; Receptors, Purinergic P2Y1 | 2013 |